TrialHead & neck2024

Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trial.

James R Janopaul-Naylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.